• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
10,064.00 119 (1.19%)
  • As on 03 Nov 2026 (EOD)
  • Today’s Low

    9,863.00
  • Today’s High

    10,064.00
  • Open

    9,965.00
  • Perv Close

    9,945.50
  • 52W Low

    5,647.50
  • 52W High

    10,064.00

Key Indicators

  • P/E(TTM)

    88.88

  • Mar.Cap (₹Cr.)

    267,167.58

  • Div & Yield %

    0.30

  • Book Value(₹)

    629.49

  • Debt-Equity Ratio

    1.19

  • AGM Date

    03-Nov-2026

  • EPS

    112.85

  • P/E Ratio

    88.88

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    267,167.58

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    629.50

  • Sales( ₹ in Cr.)

    10,388.00

  • NP (in Cr.)

    2,662.28

  • NP Var(%)

    21.0

  • Div%

    1500.0

  • CPS (₹)

    117.70

  • EPS (₹)

    100.30

  • Traded Value (₹ in Lakhs)

    264,141.24

  • 52 Week High

    10,064.00

  • 52 Week Low

    5,647.50

  • Price BSE

    9950.0

  • Price NSE

    9,946.00

  • Market Capital( in Cr.)

    264,141.24

  • P/C Ratio

    84.60

  • P/E Ratio

    99.20

  • Price Vs.BV

    100.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Other Income 506.00 352.00 337.00 349.00 111.26 62.53
Stock Adjustments 244.00 83.00 127.00 -50.00 449.99 100.00
Total Income 11,138.00 9,633.00 8,129.00 7,924.00 9,441.07 6,961.14
EXPENDITURE :            
Raw Materials 4,339.00 3,827.00 3,270.00 3,035.00 3,499.18 2,416.47
Power and Fuel Cost 530.00 465.00 477.00 496.00 390.05 319.15
Employee Cost 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Other Manufacturing Expenses 325.00 276.00 299.00 285.00 255.38 202.29
Selling and Administration Expenses 509.00 460.00 367.00 402.00 340.16 292.53
Miscellaneous Expenses 114.00 63.00 137.00 55.00 40.95 37.69
Employee Benefit Expenses 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,217.00 6,301.00 5,617.00 5,226.00 5,452.27 4,076.81
Operating Profit 3,921.00 3,332.00 2,512.00 2,698.00 3,988.80 2,884.33
Interest 24.00 2.00 4.00 2.00 1.73 1.81
Gross Profit 3,897.00 3,330.00 2,508.00 2,696.00 3,987.07 2,882.52
Depreciation 461.00 401.00 376.00 342.00 310.55 254.65
Profit Before Tax 3,436.00 2,929.00 2,132.00 2,354.00 3,676.52 2,627.87
Current Tax 869.00 793.00 511.00 438.00 637.20 609.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -40.00 -73.00 45.00 108.00 90.78 64.10
Reported Net Profit 2,607.00 2,209.00 1,576.00 1,808.00 2,948.54 1,954.72
Extraordinary Items -55.28 0.00 0.74 3.07 -1.65 -2.45
Adjusted Net Profit 2,662.28 2,209.00 1,575.26 1,804.93 2,950.19 1,957.17
Adjustment below Net Profit 6.00 -2.00 -1.00 2.00 2.18 0.16
P & L Balance brought forward 13,357.00 11,725.00 10,922.00 9,967.00 7,588.31 5,814.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 604.00 575.00 772.00 855.00 571.50 181.01
P & L Balance carried down 15,366.00 13,357.00 11,725.00 10,922.00 9,967.53 7,588.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,500.00 1,500.00 1,000.00
Dividend Per Share(Rs) 30.00 30.00 30.00 30.00 30.00 20.00
Earnings Per Share-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Earnings Per Share(Adj)-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Book Value 630.60 562.08 508.83 479.43 440.44 349.28
Book Value(Adj)-Unit Curr 630.60 562.08 508.83 479.43 440.44 349.28

Shareholding Pattern

  • Promoter Group

    51.88%

  • Public Share Holding

    48.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 8,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,715,090 48.86 129,715,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,715,090 51.88 137,715,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 4,138 0.00 4,138 5
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 37,533 0.01 37,533 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 54,092,908 20.38 54,092,908 873
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 9,237,598 3.48 9,237,598 24
Mutual Funds / UTI 38,930,687 14.66 38,930,687 49
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,681,106 1.01 2,681,106 51
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 104,983,970 39.55 104,983,970 1,005
2] Non Institution
Bodies Corporate 2,893,797 1.09 2,893,797 1,623
Clearing Members 3,265 0.00 3,265 5
Directors of their Relatives 717,045 0.27 717,045 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,184,612 0.45 1,184,612 9,340
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 291,203 0.11 291,203 3,265
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,176,805 0.44 1,176,805 6
Individuals holding nominal share capital up to Rs. 1 lakh 16,213,659 6.11 16,164,588 216,953
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 259,429 0.10 259,429 39
Others 29,705 0.01 29,705 2
Sub Total 22,769,520 8.58 22,720,449 231,245
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 265,419,509 232,256

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024
  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

    Murali K Divi

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 10,030.00 10,894.00 10,388.00 90.53 21.38
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77